All Type of News
Rapid decrease of bioequivalently-recognized medicines shows pharmaceutical companies’ hesitation over generic development
Medicines which have been newly recognized in bioequivalence test this year were 481 products, the number was decreased by almost a half compared to the last year’s same time of period.
According to the Ministry of F...
Pharmaceutical companies’ ‘two-faced’ viewpoint towards ISO37001
‘Will they move?”
The industry has paid attention to whether pharmaceutical companies will be active on the ISO 37001 certification process the Pharmaceutical and Bio-Pharma Manufacturers Association adopted as part ...
Sanofi starts Phase III clinical trial for efpeglenatide exported from Hanmi Pharm
A Phase III clinical trial for ‘efpeglenatide’ developed by Hanmi Pharm on its own and whose technology was transferred to Sanofi, a global pharmaceutical company, will start on 4 December.
On the 28th(local Korea ti...
Most common adverse drug reaction with both ETC and OTC was gastrointestinal disorder
The most common adverse drug reaction with ETC and OTC drugs was gastrointestinal disorder.
Na-Young Lee, Jung-Min Lee and Mo-Sae Lee(Korean Pharmaceutical Association Local Drug Safety Center) announced the ‘Compari...
1 of 4 listed pharmas with unsound financial structure
1 of 4 listed pharmaceutical companies were criticized as a company with poor financial structure as recording a debt rate higher than 100%.
Yakup Shinmoon(www.yakup.com) analyzed 2017 3rd quarter reports turned in b...
Listed pharmas’ overseas sales & exports
KOSDAQ pharmaceutical companies reportedly recorded a percentage of foreign sales/exports to collective sales in the 3rd quarter of this year, which is twice higher than the one recorded by KOSPI pharmaceutical compan...
Foggy future for CJ HealthCare’s disposal, but calmed atmosphere interally
The pharmaceutical industry is still highly interested in CJ HealthCare on market. This is because the company is a large company and one of the top 10 sales pharmaceutical companies, expected to be sold for about KRW...
Gilead Sciences appoints Executive Director Kwang-Gyu Park and Director Mi-Sun Yang
Gilead Sciences Korea(CEO Seung-Woo Lee) announced to appoint Executive Director Kwang-Kyu Park as Liver Disease Business Head and Director Mi-Sun Yang as HIV & Antifungal Business Head and Business Efficiency Divisio...
Korea-Uzbekistan strengthens cooperation to develop pharmaceutical industry
Korea and Uzbekistan, the two countries have decided to seek for cooperative plans to develop each pharmaceutical industry. The Korea Pharmaceutical and Bio-Pharm Manufacturers Association(Chairman Hee-Mok Won) and th...
Seocho-gu Rep. Mi-Young Choi first to table ‘Public Night Pharmacy’ support bill
Seoul Seocho-gu Rep. Mi-Young Choi tabled the ‘Public Night Pharmacy’ operation and support regulation bill.
Seocho-gu Rep. Mi-Young Choi, a former pharmacist, tabled the ‘Public Night Pharmacy Operation and Support ...
